International Patent: USE OF BCL3 INHIBITOR IN PREPARING MEDICAMENT FOR TREATING GLAUCOMA

GENEVA, Oct. 1 -- XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY filed a patent application (CN2025/127582) for “USE OF BCL3 INHIBITOR IN PREPARING MEDICAMENT FOR TREATING GLAUCOMA”. With publication no. WO/2026/188791, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/5375

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....